RecruitingNot ApplicableNCT07119515

Teletherapy vs. In-Person Cognitive Behavioral Therapy for Generalized Anxiety Disorder

A Randomized Controlled Trial Comparing Teletherapy and In-Person Third-Wave CBT for Generalized Anxiety Disorders


Sponsor

Government College University Faisalabad

Enrollment

25 participants

Start Date

Mar 10, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this randomized controlled trial is to compare the clinical efficacy of teletherapy versus in-person third-wave cognitive behavioral therapy (CBT) in treating generalized anxiety disorder (GAD) among young individuals aged 18-45 years in Pakistan. The main questions it aims to answer are: * Is teletherapy as effective as in-person therapy in reducing anxiety symptoms and stress? * Do therapeutic alliance, treatment adherence, and social support influence treatment outcomes differently across delivery methods? Researchers will compare the teletherapy group (remote sessions via digital platforms) and the in-person therapy group (face-to-face sessions) to evaluate differences in symptom reduction, general health improvement, and moderating factors like therapeutic alliance. Participants will: * Undergo a 8-week intervention with weekly structured third-wave CBT sessions. * Complete assessments at baseline, post-intervention, and follow-up using validated scales (e.g., Generalized Anxiety Disorder-7 \[GAD-7\], Hamilton Anxiety Rating Scale \[HAM-A\]). * Engage in modules including mindfulness, behavioral activation, and exposure therapy, adapted for their assigned delivery method. This study aims to address gaps in mental health accessibility in Pakistan by evaluating whether teletherapy can serve as a viable alternative to traditional in-person care.


Eligibility

Min Age: 18 YearsMax Age: 45 Years

Plain Language Summary

Simplified for easier understanding

This study is comparing two ways of delivering Cognitive Behavioral Therapy (CBT) for grief disorder — online via video (teletherapy) versus in person. Grief disorder is a condition where intense grief persists long after a loss and significantly impairs daily life. Researchers want to know if teletherapy is as effective as face-to-face CBT, which would make treatment more accessible. **You may be eligible if...** - You are aged 18–45 - You meet the DSM-5 criteria for a grief-related disorder - You can read and understand English - You have access to the internet and digital technology - You have provided informed consent **You may NOT be eligible if...** - You have active suicidal thoughts or self-destructive behavior - You have another severe mental health condition such as psychotic disorder, substance use disorder, or bipolar disorder - You have a severe personality disorder - You have a serious medical condition that could interfere with therapy Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALThird-Wave CBT via Teletherapy

Twelve weekly 40-minute remote sessions via video conferencing, including mindfulness, behavioral activation, and exposure therapy.

BEHAVIORALThird-Wave CBT In-Person

Twelve weekly 40-minute face-to-face sessions with identical third-wave CBT content.


Locations(1)

Allied Hospital II

Faisalabad, Punjab Province, Pakistan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07119515


Related Trials